
Oxford American Handbook of Oncology
Gary H. Lyman(Herausgeber*in)
Oxford University Press Inc
2. Auflage
Erschienen am 9. April 2015
Buch
Softcover
864 Seiten
978-0-19-992278-9 (ISBN)
Beschreibung
The Oxford American Handbook of Oncology is the essential reference for medical students, residents, and clinical oncologists seeking a current, portable resource on the delivery of sophisticated cancer care. Chapters focus on the immediate information needs in clinical decision making including treatment choices. Algorithms, best practice guidelines, highlighted tables, and targeted lists of landmark references enhance the concise text. For the second edition biologic therapies and therapeutic regimens and options and clinical trial information have been rigorously updated throughout.
Rezensionen / Stimmen
"[T]he authors should be commended for condensing a vast amount of information into a pocket book that practicing physicians can use as a handy reference." -- Vincent Chung, M.D. Doody'sWeitere Details
Reihe
Auflage
2nd Revised edition
Sprache
Englisch
Verlagsort
New York
USA
Zielgruppe
Für höhere Schule und Studium
Für Beruf und Forschung
Editions-Typ
Überarbeitete Ausgabe
Produkt-Hinweis
Broschur/Paperback
Klebebindung
Illustrationen
8 line art, 7 halftones, 4 color plates
Maße
Höhe: 180 mm
Breite: 102 mm
Dicke: 46 mm
Gewicht
540 gr
ISBN-13
978-0-19-992278-9 (9780199922789)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Weitere Ausgaben
Andere Ausgaben

Gary H. Lyman
Oxford American Handbook of Oncology
E-Book
01/2015
2. Auflage
OUP eBook
53,99 €
Als Download verfügbar

Gary H. Lyman
Oxford American Handbook of Oncology
E-Book
01/2015
2. Auflage
OUP eBook
53,99 €
Als Download verfügbar
Person
Gary H Lyman: Co-Director, Hutchinson Institute for Cancer Outcomes Research; Affiliate Professor, University of Washington Schools of Public Health and Pharmacy, Seattle, WA
Herausgeber*in
Professor of Medicine and Director of Health Services and Outcomes ResearchProfessor of Medicine and Director of Health Services and Outcomes Research, Division of Medical Oncology, Duke University Medical Center, Duke Comprehensive Cancer Center, Durham, North Carolina
Inhalt
Part 1 Background ; 1 Molecular cancer biology ; 2 Etiology and epidemiology ; Part 2 Cancer prevention and screening ; 3 Cancer prevention ; 4 Cancer screening ; 5 Genetic screening ; Part 3 Principles of management ; 6 Principles of cancer treatment ; 7 Surgical oncology ; 8 Principles of radiation oncology ; 9 Principles of chemotherapy ; 10 Hematopoietic stem cell transplantation ; 11 Hormone therapy ; 12 Targeted therapies ; 13 Gene therapy and immunotherapy for cancer ; 14 Complementary and alternative medicine ; 15 Clinical trials ; Part 4 Complications and supportive care ; 16 Anemia and fatigue ; 17 Febrile neutropenia ; 18 Pain management ; 19 Venous thromboembolism ; 20 Metabolic emergencies ; 21 Paraneoplastic syndromes ; 22 Superior vena cava syndrome and raised intracranial pressure ; 23 Spinal cord compression ; 24 Other obstructive complications ; 25 Late effects of cancer treatment ; 26 End-of-life care ; Part 5 Specific cancers ; 27 Thoracic cancers ; 28 Breast cancer ; 29 Gastrointestinal cancer I: esophagus, stomach, small intestine, carcinoid ; 30 Gastrointestinal cancer II: pancreas, biliary tract, hepatocellular ; 31 Gastrointestinal cancer III: colorectal, anus ; 32 Endocrine cancers ; 33 Genitourinary cancer I: renal, bladder, ureter, penile carcinomas ; 34 Genitourinary cancer II: prostate cancer ; 35 Genitourinary cancer III: testicular cancer ; 36 Gynecological cancer ; 37 Tumors of the central nervous system ; 38 Head and neck cancers ; 39 Cutaneous malignancies ; 40 Soft tissue and bone sarcomas ; 41 Acute leukemia ; 42 Chronic leukemias and myelodysplastic syndromes ; 43 Multiple myeloma ; 44 Malignant lymphoma ; 45 Cancer of unknown primary (CUP) ; Appendix